| Peer-Reviewed

Comparative Anti-mycobacterial Activity on Lowenstein-Jensen Slants of Selected Medicinal Plants Used in the Congolese Pharmacopeia

Received: 6 October 2017    Accepted: 28 October 2017    Published: 30 November 2017
Views:       Downloads:
Abstract

Tuberculosis is an infectious disease that kills approximately three million people annually worldwide. The emergence of multidrug resistant, extensively drug resistant and lengthy therapy reduces the patient compliance and therefore comprises control strategies. In this study, the leaves of Terminalia ivorensis, Carapa procera, Fagara macrophylla, Anacardium occidentale, Ficus spp. and Drepanoalpha® (a polyherbal medicine to relieve sickle cell anaemia) were extracted with petroleum ether, ethyl acetate and methanol in order to screen potential bioactive compounds in different extracts and to assess their anti-mycobacterial activity against Mycobacterium tuberculosis H37Rv and Mycobacterium tuberculosis spp. on Lowenstein-Jensen medium using a qualitative approach. The activity was determined as to whether there was growth or not. It was shown that only the methanolic extract displayed a good activity on both strains than the petroleum ether and ethyl acetate extracts. The presence of phytochemicals in plants such as alkaloids, flavonoids, tannins, saponins, anthocyanins and quinones known to be of medicinal importance pointed out a possible source for anti-mycobacterial agents to address the problem of multidrug resistance. The in vitro findings of this study provide a partial support for the use of these plants in the control of various infectious diseases as lead to drug discovery and should be reiterated and recommended for a clinical trial using an animal model.

Published in Journal of Diseases and Medicinal Plants (Volume 3, Issue 5)
DOI 10.11648/j.jdmp.20170305.12
Page(s) 88-96
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Tuberculosis, Lowenstein Jensen, Anti-mycobacterial Activity, Phytochemicals, Medicinal Plants

References
[1] Vikrant, A. A Review on Anti-Tubercular Plants. International Journal of PharmTech Research, 2011, 3(2):872-880.
[2] Lwilla, F., Schellenberg, D., Masanja, H., Acosta, C., Galindo, C., Aponte, J., Egwaga, S., Njako, B., Ascaso, C., Tanner, M. and Alonso, P. Evaluation of efficacy of community-based vs. institutional-based direct observed short-course treatment for the control of tuberculosis in Kilombero district, Tanzania. Tropical Medicine and International Health, 2003, 8(3):204–210.
[3] Muna M. B. and Fauzia R. E. G. Antibacterial Activity of Medicinal Aqueous Plant Extracts against Mycobacterium tuberculosis. Malaysian Journal of Microbiology, 2012, 8(3): 203-206.
[4] Gizachew, E. Y., Giday, M. and Teklehaymanot, T. Anti-mycobacterial Activities of Selected Ethiopian Traditional Medicinal plants used for treatment of symptoms of Tuberculosis. Global Advanced Research Journal of Medicinal Plants, 2013, 2(2):022-029.
[5] Ngbolua, K. N., Gédéon, N. B., Masengo, C. A., Djolu, R. D., Pius, T. M., Virima, M., Lassa, K. and Huruma N. T. Ethno-botanical survey and Ecological study of Plants resources used in Folk medicine to treat symptoms of Tuberculosis in Kinshasa City, Democratic Republic of the Congo. Journal of Modern Drug Discovery and Drug Delivery Research, 2014, 1(4):1-6.
[6] World Health Organization report (WHO). Global Tuberculosis. WHO Geneva, Switzerland, 2014, 171pp.
[7] Wynne, A., Jhangri, S. G., Richter, S., Alibhai, A., Rubaale, T., and Kipp, W. Tuberculosis in the era of infection with the human immunodeficiency virus: assessment and comparison of community knowledge of both infections in rural Uganda. BioMed Central International Health Human Rights, 2012, 12:36.
[8] Hudson, A., Imamura, T., Gutteridge, W., Kanyok, T. and Nunn, P. The current anti-TB drug research and development pipeline. Special Programme for Research and Training in Tropical Disease, 2003, 48pp.
[9] Kaswa, K. M., Bisuta, S., Kabuya, G., Lunguya, O., Ndongosieme, A., Muyembe, J. J., Van Deun, A. and Boelaert, M. (2014). Multi Drug Resistant Tuberculosis in Mosango, a Rural Area in the Democratic Republic of Congo. Plos One, 9(4):1-4.
[10] Ministère de la Santé Publique. Module de formation: Prise en charge de la co-infection VIH-Tuberculose au niveau du centre de santé (Niveau B). Programme National de Lutte contre le VIH et les IST, République Démocratique du Congo, 2008a, 58 pp.
[11] Ministère de la Santé Publique. Guide de prise en charge de la tuberculose PATI 4 (Health care guide of Tuberculosis). Edition 2008, Programme National de Lutte contre le VIH (HIV) et les IST (TSI), République Démocratique du Congo, 2008b, 97 pp.
[12] Bunalema, L. Anti-mycobacterial activity and acute toxicity of Erythrina abyssinica, Cryptolepis sanguinolenta and Solanum incanum. Unpublished Dissertation for Award of MSc Degree at the University of Makerere, Kampala, Uganda, 2010, 53pp.
[13] Molly, A., James, J., Misra, S. C., Sagadevan, L. D. M., Veettil, A. K. T. and Thankamani, V. Anti-mycobacterial activity of the plant extracts of Alstonia scholaris. International Journal of Current Pharmaceutical Research, 2011, 4(1):40-42.
[14] Hosseini, M. S., Wright, A., Lambregts, C., Weezenbeck, V., Nunn, P., Watt, C. S., Williams, B. G. and Dye, C. Global incidence of multi-drug resistant tuberculosis. Journal of Infectious Diseases, 2006, 194: 479-485.
[15] Corbett, E. L., Watt, C. J., Walker, N., Maher, D., Williams, B. G., Raviglione, M. C. and Dye, C. The growing burden of tuberculosis. Global trends and interactions with the HIV Epidemic. Archives of Internal Medicine, 2003, 163:1009-1021.
[16] Cooke, G. J. Public Health Africa: A Report of the Center for Strategic & International Studies (CSIS) Global Health Policy Center. CSIS, 2009, 16pp.
[17] Gandhi R. N., Nunn P., Dheda K., Schaaf H. S., Zignol M., Dick van Soolingen D. V., Jensen P. and Bayona J. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. The Lancet, 2010, 375: 1830-1843.
[18] Tijjani, M. B.; Bello, I. A.; Aliyu, A. B.; Olurishe, T.; Maidawa, S. M.; Habila, J. D. and Balogun, E. O. Phytochemical and antibacterial studies of root extract of Cochlospermum tinctorium A. rich. (Cochlospermaceae). Research Journal of Medicinal Plant, 2009, 3: 16-22.
[19] Mariita, M. R,. Callistus K. P. O. O., Oguge, O. N. and Paul O Okemo, O. P. Antitubercular and Phytochemical Investigation of Methanol Extracts of Medicinal Plants Used by the Samburu Community in Kenya. Tropical Journal of Pharmaceutical Research, 2010b, 9 (4): 379-385.
[20] Edeoga H. O., Okwu D. E. and Mbaebie B. O. Phytochemical constituents of some Nigerian medicinal plants. African Journal of Biotechnology, 2005, 4(7):685-688.
[21] Mativandlela, S. P. N. Antituberculosis activity of flavonoids from Galenia africana L. var. Africana. Unpublished Dissertation for award of PhD degree, at the Faculty of Natural and Agricultural Science, University of Pretoria, South Africa, 2009, 189pp.
[22] Mariita, M. R. Efficacy of medicinal plants used by communities around Lake Victoria region and The Samburu against Mycobacteria, selected bacteria and Candida albicans. Unpublished Dissertation for Award of MSc degree in the School of Pure and Applied Sciences, Kenyatta University, Nairobi, Kenya, 2010a, 139pp.
[23] Bukatuka F. C., Ngombe K. N., Mutwale K. P., Moni B. M., Makengo K. G., Pambu L. A., Bongo N. G., Mbombo M. P., Musuyu M. D., Maloueki U., Koto-te-Nyiwa Ngbolua and Mbemba F. T. Bioactivity and Nutritional Values of Some Dioscorea Species Traditionally Used as Medicinal Foods in Bandundu, DR Congo. European Journal of Medicinal Plants, 2016, 14(1):1-11.
[24] Asres, K., Bucar, F., Edelsbrunner, S. Kartnig, T., Hoger, G., and Thiel, W. Investigations on antimicrobial activity of some Ethiopian medicinal plants. Phytotherapy Research, 2001, 15:323-326.
[25] Aktas, E. A., Yigit, N., Ayyildiz, A. and Bastopcu, A. Comparison of the Mycobacterium growth indicator tube method and the method of proportion for drug susceptibility testing of Mycobacterium tuberculosis. Eurasian Journal of Medicine, 2014, 46:96-101.
[26] Cowan, M. M. Plant products as antimicrobial agents. Clinical Microbiology Reviews, 1999, 12(4):564-582.
[27] Malcon, S. A. and Sofowora, E. A. Antimicrobial activity of selected Nigerian folk remedies and their constituent plants. Lloydia, 1969, 32:512-517.
[28] Iwu, M. M. and Anyawu, B. N. Anti-inflammatory and anti-arthritic properties of Terminalia ivorensis. Filoterapia, 1982, 52:25-34.
[29] Agbedahunsi, M. J., Anao, I., Adewunmi, O. C., and Croft, L. S. Trypanocidal properties of Terminalia ivorensis A. Chev. (Combretaceae). African Journal Traditional, Complementary and Alternative Medicines, 2006, 3(2):51-56.
[30] Kuete, V., Sandjo, P. L., Mbaveng, T. A., Seukep, A. J., Ngadjui, T. B. and Efferth, T. Cytotoxicity of selected Cameroonian medicinal plants and Nauclea pobeguinii towards multi-factorial drug-resistant cancer cells. BioMed Central, Complementary and Alternative Medicine, 2015, 15:309.
[31] Eldeen, I. M. S. and Staden, V. J. Antimycobacterial activity of some trees used in South African traditional medicine. South African Journal of Botany, 2007, 73(2):248-251.
[32] Pereira, T. B., Rocha e Silva, F. L., Amorim, C. N. R., Melo, R. S. M., Zacardi de Souza, C. R., Eberlin, N. M., Lima, S. E., Vasconcellos, C. M. and Pohlit, M. A. In vitro and in vivo anti-malarial activity of limonoids isolated from the residual seed biomass from Carapa guianensis (andiroba) oil production. Malaria Journal, 2014, 13:137.
[33] Missah, B. Larvicidal and anti-plasmodial constituents of Carapa procera DC. (Meliaceae) and Hyptis suaveolens L. POIT (Lamiaceae). Unpublished dissertation for the award of MSc degree, Department of Pharmacognosy Faculty of Pharmacy and Pharmaceutical Sciences, Kwaume Nkrumah University of Science and Technology: College of Health Sciences, Kumasi, Ghana, 2014, 100pp.
[34] Bishola, T. T. Etude phytochimique et détermination de quelques activités biologiques de Pentaclethra macrophylla Benth (Fabaceae), Carapa procera Decne (Meliaceae) et Garcinia punctata Decne (Clusiaceae) (Phytochemical screening and assessment of biological activities of Pentaclethra macrophylla Benth (Fabaceae), Carapa procera Decne (Meliaceae) and Garcinia punctata Decne (Clusiaceae)). Unpublished Dissertation for Award of BSc Degree at the University of Kinshasa, Kinshasa, DRC, 2013, 125pp.
[35] Olugbuyiro, A. O. J., Moody, O. J. and Hamann, M. T. Anti-infective potential of some medicinal plants used in South-West Nigeria. International Journal of Innovations in Bio-Sciences, 2013, 3(3):104-110.
[36] Onasanwo, S. A., Fabiyi, T. D., Oluwole, F. S. and Olaleye, S. B. Analgesic and anti-inflammatory properties of the leaf extracts of Anacardium occidentale in the laboratory rodents. Nigerian Journal of Physiological Sciences, 2012, 27(1):65-71.
[37] Radji, M., Kurniati M. and Kiranasari A. Comparative antimycobacterial activity of some Indonesian medicinal plants against multi-drug resistant Mycobacterium tuberculosis. Journal of Applied Pharmaceutical Science, 2015, 5(01): 019-022.
[38] Nwankwo, I. U. and Ukaegbu-Obi, K. M. Preliminary phytochemical screening and antibacterial activity of two Nigerian medicinal plants (Ficus asperifolia and Terminalis catappa). Journal of Medicinal Plant and Herbal Therapy, 2014, 2(2014):1-5.
[39] Ojezele, O. M. and Agunbiade, S. Phytochemical Constituents and Medicinal Properties of Different Extracts of Anacardium Occidentale and Psidium Guajava. Asian Journal of Biomedical and Pharmaceutical Sciences, 2013, 3(16):20-23.
[40] Mpiana, P. T., Ngbolua, K. N., Tshibangu, D. S. T., Mazasa, P. P., Gbolo, B. Z., Atibu, E. K., Kadima, J. N. and Kasali, F. M. In vitro Antisickling and Radical Scavenging Activities of a Poly-herbal Formula (Drepanoalpha®®®) in Sickle Cell Erythrocyte and Acute Toxicity Study in Wistar Albino Rats. European Journal of Medicinal Plants, 2014, 4(10):1251-1267.
[41] Gaya, C. H., Kawaka, J. F., Muchungi, A. and Ngeranwa, J. J. Variation of alkaloids in the Kenyan Zanthoxylum gilletii (De Wild Waterman). African Journal of Plant Science, 2013, 7(9):438-444.
Cite This Article
  • APA Style

    Gédéon Bongo, Huruma Tuntufye, Koto-te-Nyiwa Ngbolua, Joseph Malakalinga, Tshiama Claudine, et al. (2017). Comparative Anti-mycobacterial Activity on Lowenstein-Jensen Slants of Selected Medicinal Plants Used in the Congolese Pharmacopeia. Journal of Diseases and Medicinal Plants, 3(5), 88-96. https://doi.org/10.11648/j.jdmp.20170305.12

    Copy | Download

    ACS Style

    Gédéon Bongo; Huruma Tuntufye; Koto-te-Nyiwa Ngbolua; Joseph Malakalinga; Tshiama Claudine, et al. Comparative Anti-mycobacterial Activity on Lowenstein-Jensen Slants of Selected Medicinal Plants Used in the Congolese Pharmacopeia. J. Dis. Med. Plants 2017, 3(5), 88-96. doi: 10.11648/j.jdmp.20170305.12

    Copy | Download

    AMA Style

    Gédéon Bongo, Huruma Tuntufye, Koto-te-Nyiwa Ngbolua, Joseph Malakalinga, Tshiama Claudine, et al. Comparative Anti-mycobacterial Activity on Lowenstein-Jensen Slants of Selected Medicinal Plants Used in the Congolese Pharmacopeia. J Dis Med Plants. 2017;3(5):88-96. doi: 10.11648/j.jdmp.20170305.12

    Copy | Download

  • @article{10.11648/j.jdmp.20170305.12,
      author = {Gédéon Bongo and Huruma Tuntufye and Koto-te-Nyiwa Ngbolua and Joseph Malakalinga and Tshiama Claudine and Aaron Pambu and Fabrice Mwanza and Clément Mbadiko and Gisèle Makengo and Jeff Iteku and Dorothée Tshilanda and Pius Mpiana and Théophile Mbemba and Rudovick Kazwala},
      title = {Comparative Anti-mycobacterial Activity on  Lowenstein-Jensen Slants of Selected Medicinal Plants Used in the Congolese Pharmacopeia},
      journal = {Journal of Diseases and Medicinal Plants},
      volume = {3},
      number = {5},
      pages = {88-96},
      doi = {10.11648/j.jdmp.20170305.12},
      url = {https://doi.org/10.11648/j.jdmp.20170305.12},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.jdmp.20170305.12},
      abstract = {Tuberculosis is an infectious disease that kills approximately three million people annually worldwide. The emergence of multidrug resistant, extensively drug resistant and lengthy therapy reduces the patient compliance and therefore comprises control strategies. In this study, the leaves of Terminalia ivorensis, Carapa procera, Fagara macrophylla, Anacardium occidentale, Ficus spp.  and Drepanoalpha® (a polyherbal medicine to relieve sickle cell anaemia) were extracted with petroleum ether, ethyl acetate and methanol in order to screen potential bioactive compounds in different extracts and to assess their anti-mycobacterial activity against Mycobacterium tuberculosis H37Rv and Mycobacterium tuberculosis spp. on Lowenstein-Jensen medium using a qualitative approach. The activity was determined as to whether there was growth or not. It was shown that only the methanolic extract displayed a good activity on both strains than the petroleum ether and ethyl acetate extracts. The presence of phytochemicals in plants such as alkaloids, flavonoids, tannins, saponins, anthocyanins and quinones known to be of medicinal importance pointed out a possible source for anti-mycobacterial agents to address the problem of multidrug resistance. The in vitro findings of this study provide a partial support for the use of these plants in the control of various infectious diseases as lead to drug discovery and should be reiterated and recommended for a clinical trial using an animal model.},
     year = {2017}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Comparative Anti-mycobacterial Activity on  Lowenstein-Jensen Slants of Selected Medicinal Plants Used in the Congolese Pharmacopeia
    AU  - Gédéon Bongo
    AU  - Huruma Tuntufye
    AU  - Koto-te-Nyiwa Ngbolua
    AU  - Joseph Malakalinga
    AU  - Tshiama Claudine
    AU  - Aaron Pambu
    AU  - Fabrice Mwanza
    AU  - Clément Mbadiko
    AU  - Gisèle Makengo
    AU  - Jeff Iteku
    AU  - Dorothée Tshilanda
    AU  - Pius Mpiana
    AU  - Théophile Mbemba
    AU  - Rudovick Kazwala
    Y1  - 2017/11/30
    PY  - 2017
    N1  - https://doi.org/10.11648/j.jdmp.20170305.12
    DO  - 10.11648/j.jdmp.20170305.12
    T2  - Journal of Diseases and Medicinal Plants
    JF  - Journal of Diseases and Medicinal Plants
    JO  - Journal of Diseases and Medicinal Plants
    SP  - 88
    EP  - 96
    PB  - Science Publishing Group
    SN  - 2469-8210
    UR  - https://doi.org/10.11648/j.jdmp.20170305.12
    AB  - Tuberculosis is an infectious disease that kills approximately three million people annually worldwide. The emergence of multidrug resistant, extensively drug resistant and lengthy therapy reduces the patient compliance and therefore comprises control strategies. In this study, the leaves of Terminalia ivorensis, Carapa procera, Fagara macrophylla, Anacardium occidentale, Ficus spp.  and Drepanoalpha® (a polyherbal medicine to relieve sickle cell anaemia) were extracted with petroleum ether, ethyl acetate and methanol in order to screen potential bioactive compounds in different extracts and to assess their anti-mycobacterial activity against Mycobacterium tuberculosis H37Rv and Mycobacterium tuberculosis spp. on Lowenstein-Jensen medium using a qualitative approach. The activity was determined as to whether there was growth or not. It was shown that only the methanolic extract displayed a good activity on both strains than the petroleum ether and ethyl acetate extracts. The presence of phytochemicals in plants such as alkaloids, flavonoids, tannins, saponins, anthocyanins and quinones known to be of medicinal importance pointed out a possible source for anti-mycobacterial agents to address the problem of multidrug resistance. The in vitro findings of this study provide a partial support for the use of these plants in the control of various infectious diseases as lead to drug discovery and should be reiterated and recommended for a clinical trial using an animal model.
    VL  - 3
    IS  - 5
    ER  - 

    Copy | Download

Author Information
  • Department of Biology, Faculty of Science, Kinshasa, Democratic Republic of the Congo

  • Department of Veterinary Microbiology, Parasitology and Immunology, College of Veterinary Medicine and Biomedical Sciences, Sokoine University of Agriculture, Morogoro, Tanzania

  • Department of Biology, Faculty of Science, Kinshasa, Democratic Republic of the Congo

  • Department of Veterinary Microbiology, Parasitology and Immunology, College of Veterinary Medicine and Biomedical Sciences, Sokoine University of Agriculture, Morogoro, Tanzania

  • Enseignement et Administration en Soins Infirmiers, Section Sciences Infirmières, Institut Supérieur des Techniques Médicales, Kinshasa, Democratic Republic of the Congo

  • Department of Biology, Faculty of Science, Kinshasa, Democratic Republic of the Congo

  • Department of Biology, Faculty of Science, Kinshasa, Democratic Republic of the Congo

  • Department of Biology, Faculty of Science, Kinshasa, Democratic Republic of the Congo

  • Department of Biology, Faculty of Science, Kinshasa, Democratic Republic of the Congo

  • Department of Biology, Faculty of Science, Kinshasa, Democratic Republic of the Congo

  • Department of Chemistry, Faculty of Science, Kinshasa, Democratic Republic of the Congo

  • Department of Chemistry, Faculty of Science, Kinshasa, Democratic Republic of the Congo

  • Department of Biology, Faculty of Science, Kinshasa, Democratic Republic of the Congo

  • Department of Veterinary Medicine and Public Health, College of Veterinary Medicine and Biomedical Sciences, Sokoine University of Agriculture, Morogoro, Tanzania

  • Sections